What Lam Research Actually Does
Lam Research (NASDAQ: LRCX) makes the equipment used to manufacture semiconductors — specifically etch systems (which carve circuit patterns into wafers), deposition systems (which deposit thin films layer by layer), and cleaning systems. Every major fab on the planet — TSMC, Samsung, SK Hynix, Micron, Intel — depends on Lam equipment to build chips. You cannot make advanced NAND, DRAM, or leading-edge logic at scale without it.
This matters for two reasons right now: first, AI data centers require enormous quantities of HBM (High Bandwidth Memory) and advanced DRAM, driving memory fab expansion. Second, the NAND market — Lam's largest end market — is recovering from a brutal 2023–2024 oversupply cycle. Both tailwinds are hitting simultaneously, and the numbers show it.
Q3 FY2026 Results (April 22, 2026)
- Revenue: $5.84B — +23.8% YoY | Beat est. $5.70B
- EPS: $1.47 vs $1.36 est — beat by 7.9%
- Management called it: Record revenue and earnings for the quarter
Two consecutive records. The NAND recovery is real, the HBM demand is real, and the CHIPS Act domestic fab buildout (TSMC Arizona, Samsung Texas, Intel Ohio) is generating incremental equipment spend on top of existing upgrade cycles. Lam is getting paid from all three pools at once.
The Financials (TTM through March 2026)
- Revenue: $21.68B (+26.5% YoY)
- Gross Margin: 49.98% — touching 50% for the first time
- Operating Margin: 34.26% — elite for a capital equipment manufacturer
- Net Income: $6.71B
- Free Cash Flow: $6.0B TTM (+58% YoY)
- FCF Margin: 27.7%
- Net Cash: $1.02B (net positive — more cash than debt)
- Dividend: $1.04/share, growing 13% annually
A 34% operating margin on a business making physical equipment is exceptional. For comparison, most industrial manufacturers run 10–15%. Lam's margins reflect deep customer lock-in — once a fab is built around Lam etch tools, switching costs are enormous. You don't rip out $500M in equipment mid-production run to try a competitor.
The $6B in TTM free cash flow is the number that matters most. That's the engine funding the dividend, the buybacks, and the R&D that maintains Lam's technology edge. FCF grew 58% year-over-year — the profitability inflection is accelerating, not just steady.
Forward Estimates
- FY2026 Revenue: $23.2B (+25.9%) | FY2027: $31.0B (+33.6%)
- FY2026 EPS: $5.69 (+37.6%) | FY2027: $8.18 (+43.7%)
- FY2026 FCF estimate: $5.54B
The FY2027 estimate — $31B in revenue — would represent a 68% increase from FY2025's $18.4B in just two years. That pace of growth for a company this mature is driven entirely by one structural bet: AI buildout continues at pace and memory fabs keep expanding. If that bet is right, LRCX's forward earnings curve is steep enough to justify a premium multiple. If AI spending decelerates, the forward curve flattens fast.
Valuation
- Price (July 27): ~$298
- Forward PE: ~40x (on FY2026 EPS ~$5.69)
- Price/Sales: 17.6x TTM
- Analyst consensus: Strong Buy (35 analysts)
- Avg PT: $368 (+23.5%) | UBS: $435 | High: $500
40x forward earnings is not cheap for a capital equipment company. The historical average for semi equipment names is closer to 20–25x. The premium reflects the AI spend conviction embedded in buy-side models — if FY2027 EPS of $8.18 materializes, the forward PE at current prices drops to ~36x, which becomes defensible. The market is paying for two years of earnings growth today.
Recent analyst moves: HSBC raised their target to $333 on July 27, Evercore raised to $355 on July 20, UBS raised to $435 on July 15, Needham raised to $390 on July 10. The direction of estimate revisions is uniformly up.
⚠️ Q4 FY2026 Earnings — July 29 (2 Days Away)
This is the immediate catalyst. Q4 closes Lam's fiscal year, so management will also provide FY2027 initial guidance — the most important forward-looking signal of the quarter. The market will focus on three things:
- Revenue beat or miss vs ~$6.0B est — does the record streak continue?
- Gross margin direction — are they sustaining near 50% or softening on mix?
- FY2027 guidance — does management confirm the $31B revenue trajectory or walk it back?
A clean beat + strong FY2027 guide pushes this toward $330+. A miss or conservative guide on China export headwinds (China represents ~30% of Lam's revenue) could flush it to $265–$270. This is a binary two days out — size accordingly.
Key Risks
- China export restrictions: ~30% of revenue comes from China-based customers. Any escalation in export controls is a direct revenue headwind Lam can't work around easily.
- NAND cycle timing: If memory manufacturers pull back capex faster than expected, equipment orders slow. Lam has less control over customer timing than over its own execution.
- Valuation ceiling: 40x forward PE with China risk is not a wide margin of safety. A multiple compression from 40x to 30x at flat earnings would take 25% off the stock price.
- Customer concentration: Samsung, TSMC, SK Hynix, and Micron make up a large portion of revenue. A strategic shift at any of these firms — new suppliers, capex freeze — would move the needle materially.
Position Framework
- Setup: Pre-earnings dip entry in a compounding cash machine with AI and NAND recovery tailwinds
- Entry: $290–$300 (current level) — starter size only ahead of binary
- Add zone: $265–$275 if earnings disappoint and flush (prior support area)
- Trim zone: $340–$360 post clean beat + strong guide
- Target: $368 (analyst avg) to $435 (UBS bull case) on FY2027 earnings execution
- Invalidation: Guidance cut below $27B FY2027 revenue, or close below $255 on volume
- Time horizon: 12–18 months — thesis resolves when FY2027 revenue trajectory confirms
Lam is a business you want to own in a sustained AI capex cycle. The question at $298 is whether you're buying ahead of a clean earnings print or in front of a China-driven guide-down. Two days will answer it. If you're in before July 29, keep the position sized for a potential -10% move in either direction.